- Home
- Publications
- Publication Search
- Publication Details
Title
TNF-α: a treatment target or cause of sarcoidosis?
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 29, Issue 11, Pages 2104-2111
Publisher
Wiley
Online
2015-08-26
DOI
10.1111/jdv.13246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biological agents: investigation into leprosy and other infectious diseases before indication
- (2014) João Roberto Antônio et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Efficacy of Adalimumab in Chronically Active and Symptomatic Patients with Sarcoidosis
- (2013) Lieke S. Kamphuis et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Cutaneous sarcoidosis and infliximab: evidence for efficacy in refractory disease
- (2013) Jenny Tu et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy
- (2013) Eric Russell et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2
- (2013) Yoshiaki Okubo et al. Scientific Reports
- FOXP3+T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFαAgents
- (2013) Luisa Guidi et al. Biomed Research International
- Case Series Demonstrating Improvement in Chronic Cutaneous Sarcoidosis Following Treatment With TNF Inhibitors
- (2012) Karolyn A. Wanat et al. ARCHIVES OF DERMATOLOGY
- Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy
- (2012) Jenny L. McGovern et al. ARTHRITIS AND RHEUMATISM
- Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists
- (2012) Edwina Lamrock et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids
- (2012) P. Fazzi et al. BIOMEDICINE & PHARMACOTHERAPY
- A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis
- (2012) Robert J. Pariser et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Influence of Infliximab on Cytokines Network and Markers of Bone Remodeling in Rheumatoid Arthritis Patients
- (2012) Izabela Korczowska et al. YONSEI MEDICAL JOURNAL
- TNF-α impairs differentiation and function of TGF-β-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway
- (2012) Qi Zhang et al. Journal of Molecular Cell Biology
- Efficacy and Safety of Apremilast in Chronic Cutaneous Sarcoidosis
- (2011) Robert P. Baughman ARCHIVES OF DERMATOLOGY
- Recent Advances in Sarcoidosis
- (2011) Adam S. Morgenthau et al. CHEST
- Sarcoidosis in Black Women in the United States
- (2011) Yvette C. Cozier et al. CHEST
- Inflammatory Profile and Response to Anti-Tumor Necrosis Factor Therapy in Patients with Chronic Pulmonary Sarcoidosis
- (2011) Matthew J. Loza et al. Clinical and Vaccine Immunology
- Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET
- (2011) Nils Milman et al. Clinical Respiratory Journal
- TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40
- (2011) Ryoko Hamano et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway
- (2011) S. Kant et al. GENES & DEVELOPMENT
- Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
- (2011) R. J. Erckens et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Natural but Not Inducible Regulatory T Cells Require TNF- Signaling for In Vivo Function
- (2011) W. J. Housley et al. JOURNAL OF IMMUNOLOGY
- Linkage of Type I Interferon Activity and TNF-Alpha Levels in Serum with Sarcoidosis Manifestations and Ancestry
- (2011) Nadera J. Sweiss et al. PLoS One
- Long-Term Treatment with Infliximab in Patients with Sarcoidosis
- (2011) Katrin E. Hostettler et al. RESPIRATION
- Infliximab no tratamento da sarcoidose - Experiência de um hospital central
- (2011) M. Aguiar et al. Revista Portuguesa de Pneumologia
- Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept
- (2010) S. Field et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Suppression of TNF- and IL-1 Signaling Identifies a Mechanism of Homeostatic Regulation of Macrophages by IL-27
- (2010) G. D. Kalliolias et al. JOURNAL OF IMMUNOLOGY
- Infliximab et sarcoïdose chronique. L’expérience française à propos de 31 cas
- (2010) F. Jounieaux et al. REVUE DES MALADIES RESPIRATOIRES
- Transmembrane TNF- : structure, function and interaction with anti-TNF agents
- (2010) T. Horiuchi et al. RHEUMATOLOGY
- Refractory Chronic Cutaneous Sarcoidosis Responsive to Dose Escalation of TNF-Alpha Antagonists
- (2009) A.-M. Thielen et al. DERMATOLOGY
- Variation in the Lymphotoxin-α/Tumor Necrosis Factor Locus Modifies Risk of Erythema Nodosum in Sarcoidosis
- (2009) Kathryn E. McDougal et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Clinical outcomes in sarcoidosis after cessation of infliximab treatment
- (2009) Efstratios PANSELINAS et al. RESPIROLOGY
- Sarcoidosis Appearing During Anti-Tumor Necrosis Factor α Therapy: A New “Class Effect” Paradoxical Phenomenon. Two Case Reports and Literature Review
- (2009) Alfonso Massara et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab
- (2008) Hiroki Mitoma et al. ARTHRITIS AND RHEUMATISM
- Sarcoidosis Around the World
- (2008) Om P. Sharma CLINICS IN CHEST MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started